Status:
ACTIVE_NOT_RECRUITING
Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups
Lead Sponsor:
China Medical University Hospital
Conditions:
Visual Acuity
Accommodation
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the underlying mechanisms of consuming two capsules (each containing 250 mg of Cordyceps cicadae mycelium, for a total intake of 500 mg) of Grape King's Cordyceps ...
Detailed Description
Over the past decade, vision problems caused by electronic screen use across all age groups have gradually shifted from being primarily occupational health issues to broader public health concerns. Mo...
Eligibility Criteria
Inclusion
- People with myopia less than 700 degrees
- Willing to participate in this study and sign the consent form
Exclusion
- (1) Those who have recently consumed related eye care products
- (2) Those who have had eye infections or surgery in the past three months
- (3) Those who have been diagnosed with eye diseases by an ophthalmologist (such as glaucoma, cataracts, macular degeneration, diabetic retinopathy, etc., or have undergone eye surgery such as cataract surgery, retinal laser surgery, myopia laser surgery, etc., which will be excluded before accepting the case)
- (4) Those who are allergic to cicada fungus
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07135180
Start Date
July 1 2025
End Date
December 31 2025
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung Shan Medical University Hui-Wen Lin lab
Taichung, Taiwan, 40201